Related references
Note: Only part of the references are listed.Changes in health-related outcomes among colorectal cancer patients undergoing inpatient rehabilitation therapy: a systematic review of observational and interventional studies
Sophie Scherer et al.
ACTA ONCOLOGICA (2021)
Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy
Erin M. Corsini et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)
Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen
Sun Min Park et al.
ASIAN JOURNAL OF SURGERY (2021)
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival
Johannes Thurmaier et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Hidayati Husainy Hasbullah et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
Johannes Uhlig et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial)
Troels G. Dolin et al.
BMC GERIATRICS (2021)
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
Tatsuki Ikoma et al.
BMC CANCER (2021)
Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia
Amjad Alharbi et al.
PLOS ONE (2021)
Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development
William H. Gmeiner
ONCOTARGETS AND THERAPY (2021)
The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
Xinhui Fu et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical characteristics of patients in their forties who underwent surgical resection for colorectal cancer in Korea
Chang Sin Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study
Anna Lisa Schult et al.
BMJ OPEN (2021)
High frequency of microsatellite instability and its substantial co-existence with KRAS and BRAF mutations in Vietnamese patients with colorectal cancer
Ha Thi Nguyen et al.
ONCOLOGY LETTERS (2021)
Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran
Abolfazi Yari et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
Metastatic Profile of Colorectal Cancer: Interplay Between Primary Tumor Location and KRAS Status
Zachary Zihui Yong et al.
JOURNAL OF SURGICAL RESEARCH (2020)
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China
Xiangyan Zhang et al.
PEERJ (2020)
Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases
Yaolin Song et al.
FRONTIERS IN GENETICS (2020)
Histology and its prognostic effect onKRAS-mutated colorectal carcinomas in Korea
Hye Seung Lee et al.
ONCOLOGY LETTERS (2020)
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
Liuying Zhu et al.
BIOMED RESEARCH INTERNATIONAL (2020)
BRAF Mutated Colorectal Cancer: New Treatment Approaches
Javier Molina-Cerrillo et al.
CANCERS (2020)
Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan
Hiroya Taniguchi et al.
TRANSLATIONAL ONCOLOGY (2020)
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research
Kang He et al.
ONCOTARGETS AND THERAPY (2020)
Relationship between BRAF V600E and KRAS mutations in stool for identifying colorectal cancer: A cross-sectional study
Warsinggih et al.
ANNALS OF MEDICINE AND SURGERY (2020)
Clinico-Pathological Study of K-ras Mutations in Colorectal Tumors: A Single-Center Retrospective Study of 51 Patients in Madinah, Saudi Arabia
Nasser Mulla et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
Sue Youn Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis
Yue Li et al.
CANCER MEDICINE (2019)
Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
Yuki Nagakubo et al.
BMC MEDICAL GENOMICS (2019)
Demographic trends and KRAS/BRAFV600E mutations in colorectal cancer patients of South China: A single-site report
Xinhui Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan
Muhammad Awidi et al.
PLOS ONE (2019)
Colorectal cancer patients in western Saudi Arabia Outcomes and predictors for survival over a 10-years period (2002-2014)
Marwan A. Bakarman et al.
SAUDI MEDICAL JOURNAL (2019)
Prevalence and risk factors of colorectal cancer in Asia
Martin C. S. Wong et al.
INTESTINAL RESEARCH (2019)
Protein and glycomic plasma markers for early detection of adenoma and colon cancer
Jung-hyun Rho et al.
GUT (2018)
Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients
Leila Hamzehzadeh et al.
CURRENT PROBLEMS IN CANCER (2018)
A study of BRAF mutation in colorectal carcinoma in Indian population
Shilpi Saxena et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions
Yoshifumi Shimada et al.
JOURNAL OF SURGICAL RESEARCH (2018)
Prevalence and prognostic relevance of BrafV600E mutation in colorectal carcinomas from Kashmir (North India) valley
Rafiqa Eachkoti et al.
MUTAGENESIS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study
Hiroya Taniguchi et al.
NEOPLASIA (2018)
The low prevalence of colonic serrated adenocarcinoma with high KRAS mutational status at Cipto Mangunkusumo Hospital, Indonesia
Nur Rahadiani et al.
MEDICAL JOURNAL OF INDONESIA (2018)
Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study
Mayank Jauhri et al.
TUMOR BIOLOGY (2017)
The prevalence of KRAS mutation in colorectal cancer patients in Iranian population: A systematic review and meta-analysis study
Mehrdad Payandeh et al.
BIOMEDICAL RESEARCH AND THERAPY (2017)
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
Xicheng Wang et al.
CHINESE JOURNAL OF CANCER (2017)
BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
E. Sanz-Garcia et al.
ANNALS OF ONCOLOGY (2017)
Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran
Aghigh koochak et al.
Asian Pacific Journal of Cancer Prevention (2016)
Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis
Minoru Koi et al.
GASTROENTEROLOGY (2016)
Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples
Ashraf Dallol et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
Cristiana Lo Nigro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
Roya Dolatkhah et al.
ONCOTARGETS AND THERAPY (2016)
Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman - a Single Center Study
Shiyam Kumar et al.
Asian Pacific Journal of Cancer Prevention (2015)
Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13
Hiroshi Kawamata et al.
GENOMICS (2015)
BRAFV600E mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis
Yu-jia Ma et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2015)
Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients
Nur-Afidah Mohamed Suhaimi et al.
MOLECULAR ONCOLOGY (2015)
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer
Yanhong Deng et al.
MOLECULAR ONCOLOGY (2015)
Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases
Jing Zhang et al.
SCIENTIFIC REPORTS (2015)
Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study
Takayuki Yoshino et al.
EBIOMEDICINE (2015)
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
Zachary Munn et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
Christina Therkildsen et al.
ACTA ONCOLOGICA (2014)
Clinico-Pathological Patterns and Survival Outcome of Colorectal Cancer in Young Patients: Western Saudi Arabia Experience
Shereef Ahmed Elsamany et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Spectrum of K ras mutations in Pakistani colorectal cancer patients
B. N. Murtaza et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
Yung-Bin Kuo et al.
CLINICA CHIMICA ACTA (2014)
A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
Abdul K. Siraj et al.
MOLECULAR CANCER (2014)
Analysis of KRAS Mutations in Cases of Metastatic Colorectal Cancer at a Single Institution On Tochigi, Japan
Natsuko Saito et al.
PATHOBIOLOGY (2014)
BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Dong Chen et al.
PLOS ONE (2014)
Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia
Ali Zahrani et al.
TUMORI (2014)
Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis
Talha Bader et al.
ALEXANDRIA JOURNAL OF MEDICINE (2014)
Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
Wai Kien Yip et al.
APMIS (2013)
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
Joana G. Guedes et al.
BMC CANCER (2013)
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
A. I. Phipps et al.
BRITISH JOURNAL OF CANCER (2013)
Distinct molecular features of colorectal cancer in Ghana
Leon Raskin et al.
CANCER EPIDEMIOLOGY (2013)
Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab
Christopher G. Smith et al.
CLINICAL CANCER RESEARCH (2013)
Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis
Zu-Yao Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
Ryota Nakanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
KRAS Mutational Status in Japanese Patients with Colorectal Cancer: Results from a Nationwide, Multicenter, Cross-sectional Study
Toshiaki Watanabe et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
Enric Domingo et al.
JOURNAL OF PATHOLOGY (2013)
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients
Grigoriy A. Yanus et al.
MEDICAL ONCOLOGY (2013)
Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer
N. Marchoudi et al.
PATHOLOGIE BIOLOGIE (2013)
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay
Umberto Miglio et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany
Ondrej Majek et al.
PLOS ONE (2013)
Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population
Li-Ling Hsieh et al.
CLINICA CHIMICA ACTA (2012)
The frequency and spectrum of K-ras mutations among Iraqi patients with sporadic colorectal carcinoma
N. A. Al-Allawi et al.
INDIAN JOURNAL OF CANCER (2012)
Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients
Cristina Bozzao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Amanda K. Arrington et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Clinical Outcome of Japanese Metastatic Colorectal Cancer Patients Harbouring the KRAS p.G13D Mutation Treated with Cetuximab plus Irinotecan
Hideaki Bando et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
Gholamreza Safaee Ardekani et al.
PLOS ONE (2012)
KRAS mutations and subtyping in colorectal cancer in Jordanian patients
Wafa M. Elbjeirami et al.
ONCOLOGY LETTERS (2012)
Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma
Sarita B. Bagadi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
T. Yokota et al.
BRITISH JOURNAL OF CANCER (2011)
Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathways
Toshiaki Watanabe et al.
EUROPEAN JOURNAL OF CANCER (2011)
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
Timothy J. Price et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Analysis of K-ras, BRAF, and PIK3CA mutations in laterally-spreading tumors of the colorectum
Eisuke Kaji et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers Diagnostic and Therapeutic Implications
Katharina Balschun et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue
Mi Jung Kwon et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia
Fortunato Ciardiello et al.
TARGETED ONCOLOGY (2011)
Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer
Laura S. Rozek et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
Irene Lurkin et al.
PLOS ONE (2010)
DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset
Marianne Berg et al.
PLOS ONE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
J. Souglakos et al.
BRITISH JOURNAL OF CANCER (2009)
Microsatellite Instability, MLH1 Promoter Methylation, and BRAF Mutation Analysis in Sporadic Colorectal Cancers of Different Ethnic Groups in Israel
Alex Vilkin et al.
CANCER (2009)
Genotyping of K-ras codons 12 and 13 mutations in colorectal cancer by capillary electrophoresis
Yen-Ling Chen et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer
Lisa Simi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
Ludovic Barault et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
F. Di Fiore et al.
BRITISH JOURNAL OF CANCER (2007)
Highly conserved sequence of exon 15 BRAF gene and KRAS codon 12 mutation among Greek patients with colorectal cancer
E. K. Symvoulakis et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2007)
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin
F. Bishehsari et al.
ANNALS OF ONCOLOGY (2006)
Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries
AO Chan et al.
CLINICAL CANCER RESEARCH (2005)
Mutant V599EB-RAF regulates growth and vascular development of malignant melanoma tumors
A Sharma et al.
CANCER RESEARCH (2005)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
AS Soliman et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
